Category Bilateral/Regional Negotiations

Biotech, Pharma Industries To Target IP Protection Legislation, Patent Reform

By Liza Porteus Viana for Intellectual Property Watch
When the new administration and Congress come into office following the November elections in the United States, the pharmaceutical and biotechnology industries will prioritise protection of their intellectual property and innovative biological drugs as the push for cheaper, generic versions gets stronger. Patent reform also will continue to be a lobbying priority, as well as making sure intellectual property is protected in any forthcoming international trade agreements.

L’Europe pourrait accélérer les négociations de l’ACAC

Monika Ermert pour Intellectual Property Watch Contrairement à ce que les négociateurs européens avaient affirmé au sujet du temps nécessaire pour peaufiner l’Accord commercial anti-contrefaçon (ACAC), les pays semblent à présent prêts à accélérer les négociations. La question de l’ACAC…